Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment

Дата публикации: 14-07-2026 00:00:00

This cohort study examines the absolute risk of progression to cognitive impairment and rates of cognitive decline per the blood-based biomarker plasma phosphorylated tau 217 (p-tau217) among cognitively unimpaired older adults.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	La proteína p-tau217 en sangre, clave para predecir el riesgo de Alzheimer en personas sanas con décadas de antelación	0	9.6	15-07-2026
2	Simple blood test can forecast Alzheimer’s years before memory loss	0	7.43	23-02-2026
3	Simple blood test may predict risk of developing dementia up to 10 years before diagnosis	0	15.8	15-07-2026
4	Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease	0	9.23	15-07-2026
5	Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease	0	7	15-07-2026
6	Serum GFAP Dynamics, Disease Progression, and Therapy Response in MS	0	8.04	03-08-2026
7	Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease	0	7	15-07-2026
8	Alzheimer's biomarkers may forecast dementia progression in people 80 and older	0	7	01-07-2026
9	Blood test could help identify people at high risk for Alzheimer's disease, study shows	5	7	15-07-2026
10	Valiltramiprosate lowers biomarkers in patients with Alzheimer’s	0	12.23	03-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 14.88. Источник: archderm.jamanetwork.com.